Martin Vazquez - 01 Jun 2022 Form 4 Insider Report for Outset Medical, Inc. (OM)

Signature
By: John L Brottem For: Martin Vazquez
Issuer symbol
OM
Transactions as of
01 Jun 2022
Net transactions value
-$87,682
Form type
4
Filing time
02 Jun 2022, 16:30:01 UTC
Previous filing
17 May 2022
Next filing
02 Aug 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OM Common Stock Options Exercise $19,400 +5,000 +10% $3.88* 54,237 01 Jun 2022 Direct
transaction OM Common Stock Sale $107,082 -5,000 -9.2% $21.42 49,237 01 Jun 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OM Performance Options (right to buy) Options Exercise $0 -5,000 -4.4% $0.000000 108,007 01 Jun 2022 Common Stock 5,000 $3.88 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2022.
F2 The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $20.00-$21.99 - 509 shares; $21.00-$22.99 - 4,286 shares; $23.00-$23.99 - 205 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 In March 2021, following the expiration of the lock-up period in connection with our initial public offering, the applicable performance and market-based vesting conditions were met and the shares underlying this stock option award became fully vested.